Michael Su

10.5k citations
52 papers · 9.2k · 5 hit papers · h-index 32

Impact in

  • Immunology top 0.5%
    • Immune Response and Inflammation
    • interferon and immune responses
    • Cell death mechanisms and regulation
    • Inflammasome and immune disorders
    • Melanoma and MAPK Pathways
    • Protein Kinase Regulation and GTPase Signaling

Papers in

    • Melanoma and MAPK Pathways 9
    • Cell death mechanisms and regulation 8
    • Epigenetics and DNA Methylation 5
    • Signaling Pathways in Disease 5
    • Protein Kinase Regulation and GTPase Signaling 4
    • interferon and immune responses 4

Michael Su

50 papers receiving 8.9k citations

Michael Su's Hit Papers

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo 2004 · 809 citations
8090+10+20Years since publication4008001.2k

Peers

Michael Su
Comparison fields: 5 of 132
  • Immunology 2.5k
  • Molecular Biology 6.4k
  • Cell Biology 1.1k
  • Oncology 1.4k
  • Hematology 539
Replace Patrick Matthias with:
Patrick Matthias Switzerland
Joseph T. Opferman United States
Christian Rommel United States
Sylvain Meloche Canada
Robert V. Talanian United States
Wendy J. Fantl United States
Andreas Villunger Austria
Tak W. Mak Canada
Paul G. Ekert Australia
Christopher P. Dillon United States
Michael Su relative to Patrick Matthias Switzerland Patrick Matthias's profile →
Citations per field
00.5×1.5×1.8×
Patrick Matthias · 1×
Citations per year

Countries citing papers authored by Michael Su

Since Specialization
Citations

This map shows the geographic impact of Michael Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Su more than expected).

Fields of papers citing papers by Michael Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Su. The network helps show where Michael Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Su Line = papers co-authored together Michael Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Hit paper breakdown →
19951458
2
Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9
Hit paper breakdown →
19981443
3
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Hit paper breakdown →
19971037
4
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
Hit paper breakdown →
2004809
5
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.
Hit paper breakdown →
1998505
6 1997432
7 2003267
8 1997248
9 1996215
10 1996211
11 2002210
12 1997185
13 1999178
14 1998175
15 1995147
16 1998142
17 2001131
18 1997127
19 1995121
20 1998119

About Michael Su

Michael Su is a scholar working on Molecular Biology, Immunology, Oncology, Hematology and Cancer Research, having authored 52 papers that have together received 9.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Cell death mechanisms and regulation (8 papers), Acute Myeloid Leukemia Research (7 papers), Epigenetics and DNA Methylation (5 papers), Signaling Pathways in Disease (5 papers), Microtubule and mitosis dynamics (4 papers), interferon and immune responses (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). The work is most often cited by research in Immunology (2.5k citations), Molecular Biology (6.4k citations), Cell Biology (1.1k citations), Oncology (1.4k citations) and Hematology (539 citations). Michael Su has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Keisuke Kuida, Richard A. Flavell, Yong Gu, David J. Livingston, George Ku, Matthew W. Harding, Judith A. Lippke, Tarik F. Haydar, Pasko Rakić and Chia‐Yi Kuan. Their work appears in journals such as Journal of Biological Chemistry, Blood, Cancer Research, Nature Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact